维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Gehan EA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? 显示文摘	Gehan EA Tefft MC	2000	J Natl Cancer Inst2000，2，3：	1
2	Gene Selection for Microarray Data Analysis Using Principal Component Analysis显示文摘	Gehan EA	2005	Stat Med2005，24，：	1
3	Classification of rhabdomyosarcomas and related sarcomas : pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study显示文摘	Newton WA Gehan EA Webber BL	1995	Cancer1995，76，6：	1
4	Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)?显示文摘	Gehan EA Tefft MC	2000	J Natl Cancer Inst2000，92，3：	1
5	Quantitative comparison of toxicity of antlcancer agents in mouse, rat, ham- ster, dog, monkey, and man显示文摘	FREIREICH EJ GEHAN EA RALL DP	1996	Cancer Chemother Rep1996，50，4：	1
6	The third intergroup rhabdomyosarcoma study 显示文摘	Crist W Gehan EA Ragab AH	1995	J Clin Oncol1995，13，3：	1
7	Will there be resistance to the RECIST(Response evaluation criteria in solid tumors )显示文摘	Gehan EA Tefft MC	2000	J Natl Cancer Inst2000，92，3：	1
8	Estimation of human body surface area from height and weight显示文摘	Gehan EA George SL	1970	Cancer Chemother Rep1970，54，4：	1
9	Will there be resistance to the RECIST Response Evaluation Criteria in solid tumors? 显示文摘	Gehan EA Tefft MC	2000	J Natl Cancer Inst2000，92，3：	1
10	The Intergroup Rhabdomyosarcoma Study-ll显示文摘	Maurer HM Gehan EA Beltangady M	1993	Cancer1993，71，5：	1
11	The third Intergroup Rhab domyosareoma Study显示文摘	Crist W Gehan EA Ragab AH	1995	J Clin Oncol1995，13，3：	1
12	Immunotherapy with interleukin-2 and alpha-interferon after IL-2-activated hemapoietic stem cell transplantation for breast cancer显示文摘	Arun B Gehan EA	1999	JBone Marrow Transplantation1999，23，7：	1
13	Immunotherapy with interleukin-2 and alpha-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer显示文摘	Meehan KR Arun B Gehan EA	1999	Bone Marrow Transplant1999，23，7：	1
14	Multimodal ther apy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow up of the First Inter- group study显示文摘	Nesbit ME Gehan EA Burgert EO	1990	J Clin Oncol1990，8，10：	1
15	Will There Be Resistance to the RECIST (Response Evaluation Criteria in Solid Tu mors) 显示文摘	Gehan EA Tefft MC	2000	Natl J Natl Cancer Inst2000，92，3：	1
16	The intergroup rhabdomyosarcoma study- U 显示文摘	Maurer HM Gehan EA Beltangady M	1993	Cancer1993，71，：	1
17	Muhimodal therapy for the management of primary, nomnetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study 显示文摘	Nesbit ME Jr Gehan EA Burgert EO Jr	1990	J Clin Oncol1990，8，10：	1
18	Gene Selection for Microarray Data Analysis Using Principal Component Analysis显示文摘	Wang A Gehan EA	2005	Statistics in Medicine2005，，24：	1
19	The third intergroup rhabdomyosarcoma study显示文摘	Crist W Gehan EA Ragab AH	1995	J Clin Oncol1995，13，3：	1
20	Will There Be Resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)显示文摘	Gehan EA Tefft MC	2000	J Natl Cancer Inst2000，92，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示